OUR GOAL must be to devise short-term tests for carcinogens at two levels of sophistication. Simple preliminary (Phase 1) screening tests are needed to detect carcinogens; in these, qualitative information would be acceptable. The emphasis in their design should be to provide sensitive tests which minimize species and tissue differences in response. In Phase 1 tests, false positives would be more acceptable than false negatives. Chemicals giving positive results in Phase 1 would then be examined in more elaborate (Phase 2) tests aimed at providing quantitative information and characterizing species and tissue differences in response.
To achieve broad applicability, both Phases 1 and 2 screening tests for carcinogens must incorporate two key components: a metabolism system able to generate any active metabolites which may be formed in man; and a response system which reflects the essential processes in chemical careinogenesis. It is possible to combine the metabolism and response systems in a single preparation (e.g., freshly isolated hepatocytes) but the range of potential endpoints is thereby restricted to those not involving cell division (Bridges & Fry, 1978a Since the liver is the predominant drugmetabolizing organ in all mammals, the metabolism system is normally derived from liver. Species-and tissue-specific effects tend to be lost when the liver is homogenized and fractionated. By using cellular fractions supplemented with NADPH2 the relative proportion of active metabolites is generally much greater than in intact cells, because the major conjugation enzymes (which have a predominantly detoxication role) are unable to function when they are not provided with their requisite cofactors.
Care must be taken in both preparing and storing cell fractions to ensure that there is no selective damage to the drug-metabolizing enzymes. (Microsomal amine oxidase and phenobarbitone-type cytochrome P450 are especially vulnerable to damage.) Livers from animals pretreated with various agents can be used to increase the activity of the mixedfunction oxidases and hence enhance the formation of active metabolites. However it must be borne in mind that all inducers cause a differential induction of the mixed-function oxidases, which may result in a very distorted profile of metabolites compared with the control situation. Furthermore, residues of the inducer may persist in the liver preparation, and this could cause selective inhibition of some of the enzymes of the metabolism system or modification in the response (Bridges & Fry, 1978b Interfacing the metabolism and response system Metabolites formed by the metabolism system must be able to gain ready access to the response system. The physical separation between the two systems should therefore be minimal, and the medium between the two systems should, ideally, allow free diffusion of both polar and non-polar metabolites. This is seldom accomplished in the present tests. Except in the case of aromatic amines, the major reactive metabolites tend to be lipophilic, so that for general application a lipid environment between the metabolism and response systems is more desirable than a polar one. Care must be taken to ensure that changes such as lipid peroxidation or hydrolysis of proteins in the metabolism system as a result of the action of a chemical, do not cause modifications to the response system. This is particularly important in response systems which are critically dependent on the level of nutrient in their environment, e.g. bacteria showing dependence for growth on the availability of certain amino acids.
Selection of response systems
Many biological changes have been associated with chemical carcinogens: binding of metabolites to DNA, damage to DNA and chromosomes, DNA repair, qualitative and quantitative changes in cell growth, production of abnormal ("marker") proteins, changes in antigenicity of the plasma membrane, differential changes in cellular enzymes and loss of ribosomes from the endoplasmic reticulum. In the light of our reasonably good understanding of how DNA might be involved in cancer initiation by chemicals and the paucity of our knowledge of other mechanisms of cancer initiation and post initiation events, most of the present tests are aimed, perhaps understandably, at determining endpoints associated with DNA and chromosomal changes. In view of our uncertainty about the key events in chemical carcinogenesis it is essential that in the response system particularly, Phase 1 tests should cover a variety of different biological preparations, and that some should allow for initiation events other than direct interaction of the chemical and/or its metabolites with DNA. It is important that in the development of each test the problem of false negatives and false positives is thoroughly researched in order to understand the causes of the limitations. It is essential that each test is validated using a range of chemical structures which in vivo have different tissue and species specificities. It is necessary to establish for each chemical a reproducible doseresponse relationship and to be able to distinguish between subtle changes likely to be associated in vivo with tumour development and gross effects likely to result in cell death. Much more effort must be expended on developing reliable quality control; a single chemical standard is most unlikely to be adequate to control the quality of combined metabolism and response systems.
The future
It is to be hoped that the progressive development of improved short-term approaches for detecting and characterizing carcinogens and related compounds will not be inhibited by the natural desire to obtain rapidly a universal short-term test for screening carcinogens. BACTERIAL MUTATION TESTS fall into a general category of short-term assays for carcinogen screening which are based on the unifying hypothesis that carcinogens characteristically react with, modify, induce the repair of, interrupt the replication of, or otherwise alter the structure, function or subsequent fate of DNA; in other words, most carcinogens have been found to cause DNA damage. The detection of DNA damage has therefore become a major preoccupation of those interested in determining which, of those many thousands of chemicals already in use, or in development, are most likely to have carcinogenic properties. At present, the most sensitive, reliable, rapid and universally applicable methods for detecting DNA damage are those based on bacterial mutation.
Mutation may be defined as a stable heritable change in a DNA nucleotide sequence which is detected as a phenotypic change. Such heritable changes may be due to base substitutions (transitions, transversions) frame shifts (deletion or addition of one or few nucleotide pairs) large deletions, insertions or translocations. Few if any mutagens induce only one type of mutational change, but instead exhibit a characteristic mutational spectrum which depends on the nature of the primary DNA alteration (modification of a base, phosphate or sugar, strand break, or incorporation of a modified base) and the secondary effects of the organisms' response to the DNA alteration, by the operation of various DNA-repair systems and by replication of daughter strands upon a modified template. The same mutagen may therefore induce different mutational patterns in organisms of different genetic background.
Mutations may be detected by methods which assay for forward or reverse mutation. Forward mutation (e.g. from drug sensitivity to drug resistance) have the theoretical advantage of presenting a large genetic target and should therefore detect many of the DNA alterations mentioned above, including deletions, all of which may be expressed by the same phenotype. Reverse mutation assays (e.g. amino acid auxotrophy to prototrophy) use bacteria already mutant at an easily detected locus, and the test consists of determining the rate at which the test chemical induces a second mutation which abolishes or suppresses the effect of the preexisting mutation. The genetic target is therefore small, selective and specific. Several
